Screener
Illumina ILMN Q2 2026 earnings
Reported July 30, 2026 · After market close
Revenue$1.2BBeat by $28.4M
Adjusted EPS$1.31Beat by $0.08
Revenue estimate$1.1B
EPS estimate$1.23
“Demand for NovaSeq X remains high as we expand our workflow and multiomics capabilities, broadening the value of Illumina's ecosystem.”
Earnings data and commentary were extracted with AI from company filings and may contain errors. Verify important details in the filing.
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$1.2B
EPS estimate$1.38
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Illumina report Q2 2026 earnings?
- Illumina (ILMN) reported Q2 2026 earnings on July 30, 2026 after market close.
- What were Illumina's Q2 2026 revenue and EPS?
- Illumina reported revenue of $1.2B and adjusted eps of $1.31 for Q2 2026.
- Did Illumina beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $1.1B by $28.4M. EPS beat the consensus estimate of $1.23 by $0.08.
- How did Illumina's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 9.4% from $1.1B a year earlier.
- Where can I find Illumina's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001110803-26-000155) and the 10-Q periodic report (0001110803-26-000160) directly on SEC EDGAR. The filing index links above go to sec.gov.
